RNA-seq analysis of human pancreas cell line SU8686 treated with DOT1L inhibitor (SGC0946) or DMSO

ABSTRACT: To understand the pathway alteration associated with DOT1L inhibition, we performed RNA-seq analysis of DOT1L inhibitor treated human pancreas cell line SU8686. We reported the changed pathways.

ORGANISM(S): Homo sapiens

PROVIDER: GSE139070 | GEO | 2021/06/23

REPOSITORIES: GEO